SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " treatment " 1,578 found 🔀 AI-powered Shuffle
NC leader to encourage mental health treatment without commitment to psychiatric facility
North Carolinians who are suffering from mental illness are sometimes required by judicial officials to undergo treatment at a psychiatric facility — a process that could become more flexible if lawmakers take up a proposal expected Tuesday.
GLP-1 drugs like Ozempic show promise for more than weight loss. But what’s science vs hype?
Ozempic-style drugs have been flagged as possible treatments for cancer, dementia, endo, addiction and more. An expert explains what the evidence really says.
As Ebola Spreads, Scientists Race to Find Vaccines and Treatments
The Bundibugyo virus, a little known type, previously had caused just two small outbreaks. Now it’s at the center of a rapidly widening epidemic in Africa.
A famed folk-rock duo gets the musical treatment at Village Theatre
“We Ain’t Ever Gonna Break Up,” on stage at Village Theatre, loosely maps the tumultuous relationship of obvious analogs Simon & Garfunkel.
Baldur's Gate 2 remake reportedly in the works at Wizards of the Coast, with the first game "likely" getting the same treatment too
A rumour regarding Baldur's Gate's future says BG2 is being remade, maybe alongside the original, and co-lead designer Kevin Martens is involved.
Ebola Scares In Brazil, Italy Prompt Fears Of Global Spread (Live Updates)
Protesters in Kenya are protesting plans by the U.S. to build a quarantine and treatment center at Laikipia Air Base.
The Back Pain Myths Patients Still Believe. And What Science Says Instead
Low back pain is one of the most common and misunderstood health problems in the world. Affecting 619 million people globally in 2020, it is now the single leading cause of disability worldwide, according to the World Health Organization (WHO). Yet despite how widespread it is, many people still make care decisions based on myths that can push them toward fear, inactivity, unnecessary treatment, and confusion before they understand what helps.
Confirmed Ebola cases in Congo reach 282 as survivors describe their recoveries
The outbreak remains focused in Congo's eastern Ituri province. Congo has reported over 1,000 suspected cases with the Bundibugyo virus, which has no approved treatment or vaccine.
Healing first: How Mendota Juvenile Treatment Center is succeeding
Mendota Juvenile Treatment Center in Madison provides care to some of Wisconsin's most troubled young people. It plans to expand.
Explore the engine accelerating new cancer treatments at UT San Antonio
See how the university is spurring the path from discovery to care, expanding access to advanced cancer treatments and clinical trials.
Role of Physical Activity in Obesity Treatment and Cardiometabolic Health
Obesity affects 42% of adults in the United States and is strongly associated with major cardiovascular disease risk factors, including high blood pressure, abnormal cholesterol levels, and insulin resistance, making effective obesity treatment a critical public health priority.
Experimental drug shows promise against deadly pancreatic cancer
A novel pill helped people with advanced pancreatic cancer live longer, researchers reported Sunday, raising hopes of long-needed better treatments for one of the deadliest types of cancer.
WHO chief reports 5 Ebola recoveries as new treatment center opens in Congo
Five patients have recovered from a rare type of Ebola virus, the head of the World Health Organization said Sunday during a visit to Bunia in eastern Congo.
Community unites for Fenway Health’s Strides for Action 5K in Boston
Hundreds of advocates and community leaders came together Sunday morning to support HIV prevention and treatment, LGBTQIA+ health services, research, and advocacy.
Why Trump reversed course to fast-track psychedelic drugs for mental healthcare
President Donald Trump is trying to fast-track research into psychedelics as treatments, creating new opportunities and risks.
WHO chief hails 5 Ebola recoveries as a new treatment center opens in eastern Congo
The World Health Organization reports that five patients have recovered from a rare type of Ebola in eastern Congo.
WHO chief hails 5 Ebola recoveries as a new treatment center opens in eastern Congo
The World Health Organization reports that five patients have recovered from a rare type of Ebola in eastern Congo.
How Nigeria’s ‘algorithmic apothecary’ fuels a surge in risky herbal cures
Unverified herbal remedies promoted on social media are driving rising health risks and delayed treatment in Nigeria.
Governor Gianforte Announces Montana Secures Federal Funding to Establish Behavioral Health Clinics
HELENA, Mont. – Governor Greg Gianforte and Department of Public Health and Human Services (DPHHS) Director Charlie Brereton today announced the Trump administration selected Montana as one of ten states to receive federal funding to expand access to mental health and substance use disorder treatment across the state.
HHS Unveils Sweeping Plan to Combat Lyme Disease and Advance Treatment
U.S. Health and Human Services (HHS) Secretary Robert F. Kennedy, Jr. today announced a series of major initiatives to strengthen the nation’s response to Lyme disease and other tick-borne illnesses.
3 receiving preventive treatment after exposure to rabid bat in Snohomish County home
Three Snohomish County residents are receiving preventive treatment for rabies after being exposed to a bat that tested positive for the virus, county health of
What to know about the Bundibugyo virus, form of Ebola causing an outbreak in Congo
The virus causing an outbreak in Congo suspected of killing more than 200 people is less common than others that cause Ebola disease, which is complicating the response because there are no specific treatments or vaccines.
Reducing the Stigma Around Mental Health
We have to engage with skeptics if we want people to accept that mental health conditions require medical treatment.
The woman behind the world’s biggest longevity competition
Jamie Justice of XPRIZE Healthspan on the most promising research and "purely scammy" treatments in the world of longevity.
Bone Health During Breast Cancer
Some breast cancer treatments lower estrogen and can weaken bones. Find out why and how to keep your bones strong during treatment and beyond.
Chris Evert says Jannik Sinner 'shouldn't have been allowed' to leave court during French Open controversy
Chris Evert draws the line on star treatment in tennis, saying Sinner's French Open medical timeout violated clear rules on cramping timeouts.
Americans who get Ebola will go to Europe for treatment, not U.S., officials say
Trump administration officials said the CDC and State Department are working to figure out where those treatment facilities could be.
HIV, Brain Health Research, and How It Could Benefit Everyone
Brain health research in people living with HIV could improve existing treatments and facilitate discovery of new interventions for other diseases.
Forget LASIK: Safer, cheaper vision correction without lasers or surgery
Researchers are developing a futuristic alternative to LASIK that reshapes the eye without lasers or incisions. Using mild electrical pulses and platinum contact lenses, they temporarily soften the cornea so it can be molded into a new shape. Early tests on rabbit eyes successfully corrected nearsightedness in about a minute while preserving the eye’s structure.
Medicaid’s Vital Role in Mental Health and Substance Use Disorder Care
Mental Health Awareness Month is an opportunity to recognize Medicaid’s essential role in helping people access mental health care and treatment for substance use disorder. As the nation’s largest payer for mental health and substance use disorder care, Medicaid covers approximately twenty two million non-elderly Americans with these conditions who rely on the program’s essential […]
HEALTH FIRST: Technology advancements in cancer treatment
Advancements in cancer treatment are giving patients new options.
New depression treatment targets the immune system instead of the brain
A surprising new approach to depression treatment is showing early promise — not by targeting brain chemicals, but by calming the immune system. In a small clinical trial, researchers found that an anti-inflammatory drug normally used for rheumatoid arthritis appeared to ease symptoms in people with hard-to-treat depression, while also reducing fatigue and anxiety and improving quality of life.
In Good Health: Chronic Pelvic Pain In Women
Chronic pelvic and vulvovaginal pain is surprisingly common among women of all ages. In fact, 1 in 3 women will experience a pelvic floor disorder at some point in their lifetimes.So, why is it so difficult to receive diagnosis and treatment for these conditions? And why don’t we talk about our pain ‘down there’ in general?In this installment in our series, “In Good Health,” we sit down with a panel of experts to talk about it.Find more of our programs online. Listen to 1A sponsor-free by signing up for 1A+ at plus.npr.org/the1a.
Scotland Health’s home-based care program earns AHA Rural Hospital Excellence in Innovation Award recognition
Scotland Health at Home began with one goal: Connect patients to treatment, no matter where they were.
Dragon Quest XI Gets The 'Definitive Edition' Treatment (Again) For Switch 2
Dive back in this September
Ebola, chemical plants and health, hantavirus, common colds, heat and more
As they say, bugs have ears. Public health has had a relentless May. Chemical plant (near) explosions, Ebola, hantavirus, and that's before you even get to the usual suspects: common colds, heat, and ticks. Here’s an attempt to keep you up to speed and, more importantly, what it means for you and your community. But first, an announcement: World Cup The World Cup starts in 15 days (not like anyone is counting down), and we are hanging TVs in the Health Security Operations Center. It’s going to be a gorgeous, chaotic celebration of basically every culture on earth. And it’s going to take a team effort—from communities to individuals, from public health to health care—to keep people healthy. That’s where you come in. If you’re going to the games or live within 30 miles of a stadium, we would love to hear from you. Sign up for a weekly survey here. Thanks to the more than 1,280 people who have already signed up…you will be hearing from us soon!! Global disease “weather report” Hantavirus: Two more cases The global count of cruise ship passengers with hantavirus has now increased to 13 cases (11 confirmed), with three deaths. The two new cases are overseas and among people who were already quarantining: A crew member in the Netherlands. A Spanish national passenger who was quarantining at home tested positive through daily monitoring. They are now in a biocontainment unit. In the U.S., everyone remains negative. There may be more cases, given that the incubation period of hantavirus (the time from exposure to infection) is 45 days. But this week, we will reach a major milestone: the median incubation window is 18 days, and that will pass on May 29. What this means for you: Your risk from this cruise ship outbreak remains essentially nil at this point. Ebola rages on in Central Africa Big thanks to Dr. Craig Spencer, a humanitarian physician who has treated and survived Ebola, for jumping in to provide the YLE community with an update. Craig, take it from here… The combined confirmed and suspected Ebola cases in DRC are now more than 1,000. All signs are pointing to a very long and catastrophic outbreak in Central Africa: This is a vast undercount. We know this because the test positivity rate is hovering around 50%, only 20% of contacts are being traced (and in some areas, no contacts at all), and more cases keep popping up with no known connection. This all points to widespread and undetected community transmission. This is in only a week of detection. Compared to previous outbreaks, the growth is very fast, as the huge West Africa outbreak in 2016 was first detected at 49 cases and rose to 208 cases a month later. It took four months for that outbreak to reach the size of the current one in the DR Congo. The cases are spread out across 16 health zones. There are now multiple epicenters, making containment very difficult. Next door in Uganda, the case count is seven. While this number is low compared to DRC, a concerning development is that two health care workers recently tested positive with uncertain exposure histories. If they weren’t treating known Ebola cases, this means it’s spreading undetected in Uganda as well. On the ground, backlash, including the burning of health centers, has emerged, a pattern seen in nearly every outbreak and rooted in deep community distrust. It often stems from outside actors working in communities without fully understanding or addressing local priorities. Affected populations may recognize the severity of Ebola while still holding other concerns as more pressing, such as where their loved ones are buried. Community trust is essential to an effective response, but difficult to build during an active emergency. It is best established long before a crisis begins. U.S. priorities are made clear, and may backfire. The U.S. Administration has shown that its first priority is keeping Ebola out, with helping end the outbreak in the DRC a secondary concern. That's meant travel restrictions broader than anything we've imposed before — covering travelers from across the region, and reportedly some green card holders and permanent residents as well. For example, just these past two days, news broke that high-risk American travelers will be subject to a mandatory quarantine in Kenya before they are allowed to return. If an American is infected, the U.S. government plans to send them to a hospital it is standing up from scratch in Kenya. (Currently, Americans who were in the area are allowed to return but are diverted to three airports—Houston, Atlanta, and DC—for further screening.) Past administrations have used travel notices and stepped-up screening; this goes much further. At first blush, these strict precautions may sound prudent. But this approach could backfire in three ways: Restrictions this blunt give people every reason to hide where they’ve been and whom they’ve been near — making the people we most need to find harder to track, not easier. They also breed a false sense that this is someone else’s problem. But diseases are humbling. They find the small cracks in even the most impenetrable-seeming defenses. Lives lost. There is no treatment for this Ebola strain, which means survival depends heavily on the quality of the health system. We have that system in the States, but we are choosing not to use it for infected Americans. This is unbelievable and infuriating. (See a deeper dive from me here.) The only real way to lower the risk to Americans — and everyone else — is to end the outbreak in the DRC and across the region. What this means for you: If you have travel plans to this region, it’s time to cancel them. This is a high-risk situation in Central Africa, and CDC released a Level 4 Travel Advisory. There is also great uncertainty if and when the Administration will let you back in. To the general public in the U.S., your risk remains very, very low right now. U.S. disease “weather report” Ticks: past peak season? Good news, especially for people in the Northeast and Midwest: tick numbers continue to decline. Though we are at the peak of the season, this unusually early year is trending favorably. Heat-related illnesses in the North Heat risk is certainly not blanketing the entire country yet, but this week it will be moderate in the Midwest and the Southeast. What this means for you: Be sure to check the CDC HeatRisk tool. A red day isn’t the best day for that soccer game for a kid with asthma, and a stretch of orange days is a great time to check on your elderly neighbor. Common colds surging As far as respiratory viruses go, the only thing really going around right now is the common cold. It is higher this year than last year, but should peak very soon before returning this fall. Spotlight: Chemical plants Over the weekend, YLE California covered the serious situation that unfolded around a chemical plant in Orange County, California. Thankfully, the worst-case scenario (a chemical explosion) was mitigated, but only through luck. The health implications in a densely populated area could have been catastrophic. As the situation was winding down, another chemical explosion struck Washington State. This one was fatal. Health officials say the risk to surrounding residents from chemicals in the air and ground remains low, though the community deserves far greater clarity. Clean air and clean water consistently rank as Americans’ top public health concerns — yet when chemical disasters strike, communities are too often met with reassurances rather than transparency and accountability. Residents near the 2023 East Palestine, Ohio train derailment, for example, are still waiting to understand the long-term impact on their health, with few clear answers. What this means for you: Many are wondering if facilities processing potentially dangerous materials are in their neighborhoods. This interactive map allows you to enter your ZIP code and see all facilities monitored by the EPA, including any violations. Good news Ebola vaccines and treatment for the Bundibugyo species are in development. Two vaccine platforms are being explored, at least one of which may be deployable in as little as 2 months. One vaccine is being developed by Oxford, and the other uses the same biotechnology as the FDA-approved Zaire species of Ebola. (It may provide cross-protection, but it’s unclear at this point.) On the treatment side, two promising monoclonal antibody cocktails are likely to be deployed, though doses are limited and logistical hurdles remain significant challenges. Anni over at The Biotech Tea had a great explainer about the Ebola vaccine gap, if you want to read more. [ The Biotech Tea The Ebola vaccine gap, reading vessel damage, & the Makary exit 🗝️ Paid subscribers get the Biotech Term of the Week at $30/year (~$2.50/month). I try to keep it intentionally accessible, but if cost is ever a barrier, send me a message. A few people asked about expensing your subscription, so I put together a short email template… Read more 6 days ago · 10 likes · Annicka Evans, PhD ](https://www.thebiotechtea.com/p/the-ebola-vaccine-gap-reading-vessel?utm_source=substack&utm_campaign=post_embed&utm_medium=web) Polycystic ovary syndrome (PCOS) has been officially renamed polyendocrine metabolic ovarian syndrome (PMOS), following more than a decade of debate and input from roughly 22,000 clinicians, researchers, and patients worldwide. This is good because the old name was medically misleading, leading to patients without visible cysts being dismissed or overlooked entirely. The WHO estimates that 70% of people with the condition remain undiagnosed. A more accurate name should improve recognition, reduce stigma, and ultimately help the millions of people living with this condition get diagnosed and treated sooner. Poll Loading... Bottom line Public health situations are everywhere right now. Staying healthy takes public health professionals and systems working tirelessly behind the scenes and each of us showing up for our neighbors and communities. Love, YLE Big thanks to Ed Nirenberg for staying on top of the Ebola vaccines, Hannah Totte for all the figures, Dr. Craig Spencer for the Ebola insight, and Dr. Matt Willis for covering the chemical situation in CA. Your Local Epidemiologist (YLE) comprises a team of experts, ranging from physicians to immunologists to epidemiologists to nutritionists, working together with one goal: to “Translate” ever-evolving public health science so that people are well-equipped to make evidence-based decisions. YLE suite of newsletters reaches over 475,000 people across more than 132 countries. This newsletter is free to everyone, thanks to the generous support of fellow YLE community members. To support the effort, subscribe or upgrade below: Subscribe
Banner Health report shows Arizona research driving national medical innovation
Milestones in Research details 1,300 clinical and translational research studies, FDA-approved heart device, landmark Alzheimer's prevention work Dr Wilber Su Wilber Su, MD, cardiologist for Banner Health, in the operating room. Phoenix, May 26, 2026 (GLOBE NEWSWIRE) -- Banner Health's $80.5 million research enterprise delivered breakthrough treatments to Arizona patients in 2025 while advancing wide-ranging therapies toward FDA approval, according to the organization's annual Milestones in Rese
Why is hantavirus so deadly? It’s not what you may think
Andes hantavirus causes deadly lung failure, but its method of attack differs from other respiratory illnesses. The details might inform future treatments.
Scientists say they’ve reversed brain aging with a simple nasal spray
Researchers at Texas A&M have developed a nasal spray that appears to reverse brain aging by calming inflammation and restoring the brain’s energy systems. After just two doses, memory and cognitive function improved for months, raising hopes for future treatments targeting dementia and brain fog.
‘The patient is a VIP’: Inside Jeffrey Epstein’s close ties to Mount Sinai Hospital
Epstein’s special treatment from the hospital included doctors being at his beck-and-call, including for house calls, and giving preferential treatment to his friends for medical care and job prospects.
DRC is no stranger to Ebola outbreaks. Why isn’t there a vaccine or treatment to help now?
The fast-growing Ebola outbreak in the Democratic Republic of Congo came to the world’s attention only a little more than a week ago and is already the third-largest on record. But it’s the 17th outbreak the country has dealt with since the virus was discovered there in 1976.
Leo International Precision Health AG builds a Synchronised, End-to-End Precision Healthcare Engine Across the Entire Patient Journey
LIPH AG introduces a synchronised “Precision Health Engine” designed to transform healthcare from reactive treatment into predictive, personalised and continuous care. Planegg / Martinsried, Germany, May 26, 2026 – Leo International Precision Health AG (“LIPH AG” or the “Company”, ticker symbol: LEOW), a holding company building a global AI-driven healthcare ecosystem and listed on the Frankfurt Stock Exchange, continues to expand its precision health platform integrating Healthcare Services, Me
African Health Officials On Ebola: ‘This Is Too Much’ (Live Updates)
Several treatment centers have been destroyed and tensions are rising in Congo, the center of the Ebola outbreak.
Common heart drug taken by millions found useless
A massive international study could upend 40 years of heart attack treatment. Researchers found that beta blockers—routinely prescribed after uncomplicated heart attacks—offered no real benefit for patients whose heart function remained normal, despite being given to millions worldwide. Even more surprising, women taking the drugs faced a higher risk of death, repeat heart attack, or hospitalization for heart failure compared to women who didn’t receive them.
Attacks on Ebola treatment centers are one of several problems affecting Congo's outbreak response
Experts say several crises combine to make the Ebola outbreak in eastern Congo difficult to contain.
Attacks on Ebola treatment centers are one of several problems affecting Congo's outbreak response
Experts say several crises combine to make the Ebola outbreak in eastern Congo difficult to contain.
Attacks on Ebola treatment centers are one of several problems affecting Congo's outbreak response
Experts say several crises combine to make the Ebola outbreak in eastern Congo difficult to contain.
Political Division Is Damaging Therapeutic Alliances
Opposing views between patients and therapists related to the Palestinian-Israeli conflict have led to ruptured treatment. It is the patients who are harmed.
Scientists say house cats could help unlock new cancer treatments for humans
Scientists have cracked open the “black box” of feline cancer in a landmark study that genetically analyzed nearly 500 cat tumors from around the world. The research uncovered striking similarities between cancers in cats, dogs, and humans — including shared cancer-driving genes tied to aggressive breast cancers.
Second Ebola treatment center set on fire in epicenter of disease's outbreak
A second Ebola treatment center is set ablaze in eastern DR Congo, with 18 suspected cases fleeing
Angry residents of a town at the epicenter of the Ebola outbreak in eastern Democratic Republic of Congo (DRC) attacked and burned a tent that was part of a health center where people are being treated for the virus, the staff there said Saturday. It was the second such attack in the region in a week.
Eighteen suspected Ebola patients escape after treatment tent is set on fire for a second time in Congo
A tent used for treatment of the Ebola outbreak in eastern Congo was set on fire for the second time this week, and 18 people suspected of infection escaped, a local hospital director said Saturday.
5 Takeaways From a Times Investigation on Autism Therapy Clinics
A rapidly growing industry often overprescribes treatment to young children with autism, who spend as many as 40 hours a week at the facilities.
People with eating disorders are taking GLP-1s and doctors are alarmed
Providers said they are encountering patients seeking treatment for anorexia, bulimia and binge eating disorder who are taking GLP-1 drugs.
Ebola outbreak live updates: WHO upgrades risk to 'very high' and warns virus 'spreading rapidly'
Meanwhile, an American doctor who was flown to Germany for treatment after contracting the virus in the Democratic Republic of Congo is "critically ill," his missionary group says.
Anavex Life Sciences Receives Expected Nasdaq Delinquency Notification
Anavex Life Sciences Corp. (“Anavex” or the “Company”)(Nasdaq: AVXL), a clinical-stage biopharmaceutical company focused on developing innovative treatments for central nervous system (CNS) disorders, today announced it received anexpected delinquency notification letter (the “Notice”) from the Listing QualificationsDepartment of The Nasdaq Stock Market LLC (“Nasdaq”) on May 20, 2026.
World Health Assembly endorses resolution on precision medicine
At the Seventy-ninth World Health Assembly, Member States endorsed a new resolution on Precision medicine: a path towards targeted, personalized and equitable care, taking an important step towards advancing precision medicine as part of efforts to strengthen equitable, effective and sustainable health systems. Precision medicine refers to the use of clinical, molecular, genomic and other health data to inform prevention, diagnosis and treatment, taking into account variability while applying appropriate ethical and legal safeguards. When integrated responsibly into health systems, precision approaches can improve outcomes across different disease areas and across the life course – from cancer and rare diseases to infectious diseases, maternal, newborn and child health, mental health and noncommunicable diseases. The resolution reflects rapid advances in genomics, diagnostics, data science and digital health, alongside widening global inequities in access to these innovations. Many populations – particularly in low- and middle-income countries – remain underrepresented in data and research, limiting the public health impact of precision medicine and risking the widening of health disparities if action is not taken now. "Precision medicine is not an aspirational idea for health delivery in the future – it is already transforming lives across the world. But its benefits remain out of reach for too many and the research driving progress is concentrated in high income countries. This WHA resolution gives global health leaders, ministries of health, and WHO a clear mandate: to act. From infant screening to setting up genomic databases WHO will work with countries to bring about the power of these innovations." Dr Meg Doherty, Director Science for HealthThrough the resolution, Member States commit to developing and strengthening national policies, infrastructure, workforce capacity and governance frameworks to support the safe, ethical and equitable integration of precision medicine into health systems, aligned with universal health coverage. This includes promoting affordability, ensuring inclusive research and data systems, strengthening regulation and data governance, and fostering collaboration across sectors and regions.WHO is requested to provide technical and normative support, review and coordinate existing guidance, facilitate global and regional collaboration, and develop a Global Strategy on Precision Medicine to guide equitable and context‑appropriate implementation. WHO stands ready to support Member States through tools such as a country maturity model for countries to self-assess capacity in implementing precision medicine depending on their context. In the immediate term WHO will map all existing guidance and frameworks and host extensive consultations with interest holders globally.By placing equity, inclusion and public value at the centre of precision medicine, the resolution reinforces WHO’s commitment to ensuring that scientific advances benefit all people, everywhere, and that no one is left behind in the next era of health innovation."By uniting people-centered healthcare with innovation, precision medicine has the potential to transform lives. This resolution helps ensure those advances serve the shared goal of health for all." Dr Sylvie Briand, Chief Scientist For further information please visit the Health Topic: Genomics
Ebola treatment center in Congo set on fire as fear and anger over disease's spread grow
People set fire to an Ebola treatment center in a town at the heart of the outbreak in eastern Congo as fear and anger grow over a health crisis that doctors are struggling to contain.
3 Medical Routines That Older People May Not Need
Some screenings and treatments no longer make sense for patients as they age. Researchers have just added a few more to the list.
New Orleans hospital offers new radiotherapy that tracks tumors during treatment: 'More precise, more personal'
"Less recurrence. More cure. Less side effects. Better patient experience," said Dr. Christophe Marques, a radiation oncologist with Ochsner Health.
Guzman Y Gomez Gives Up on Failing US Business; Shares Soar
(Bloomberg) -- Australian burrito chain Guzman y Gomez Ltd. said it’s closing its Chicago restaurants and exiting the US after failing to generate adequate sales. The company’s shares soared.Most Read from BloombergSpot the Difference: Putin Gets Trump Treatment From Xi in ChinaIran Says the US’s Latest Proposal Has ‘Narrowed the Gaps’Modi’s Toffee Gift to Meloni Ignites Rally in Wrong Indian StockIran in Talks With Oman Over Permanent Hormuz Toll SystemDow Average Climbs to Record on US-Iran De
Popular weight loss drugs like Wegovy may also target arthritis inflammation
Researchers have discovered that the GLP-1 hormone targeted by drugs like Wegovy is present in very low amounts inside the joints of arthritis patients. That finding suggests high-dose GLP-1 medications could potentially reach the joints and influence inflammation directly, not just help through weight loss. Scientists say this could open the door to a completely new approach to arthritis treatment.
Exclusive | San Diego mosque shooter walked out of mental health treatment center the day before massacre, police had prior warnings: sources
AI & Science: What Is the Future of Discovery?
Continued progress in artificial intelligence, its expanding usefulness in science, and its contributions to landmark advances suggest that we may have entered a new era of AI for science.The breakthroughs so far—such as predicting the structure of practically every known protein, with profound implications for our understanding of biology, health, and the treatment of disease—are notable not only for what was achieved but also how it was achieved and what that suggests for scientific progress. This special double issue of Dædalus poses the question: What is the future of scientific discovery in this new age of AI? Thirty-three scientists responded. Bringing perspectives from life sciences and medicine, cognitive science and neuroscience, the physical and earth sciences, chemistry and materials science, computer science, mathematics and the social sciences—they draw on their work at the frontier of AI and science. The authors write with an eye to the future, not just the present. They explore what is being achieved and what possibilities lie ahead; examine AI’s limitations and efforts to move forward; and investigate the larger implications of AI-assisted science—on how science is done, the role of the scientist, and the scientific method, as well as the challenges and complexities involved.The authors together exemplify a long-standing bidirectional relationship: AI advancing science, while science advances AI. Where that relationship will take us—a golden age of discovery? New scientist-machine collaborations? Autonomous labs? Discoveries without human understanding?—is a future we are only beginning to imagine, and one we must also shape if the beneficial possibilities are to be realized.Image: UMAP sculptures visualizing three Dædalus volumes on artificial intelligence. © 2026 by Refik Anadol.
Chase Travel plays a starring role when entertainment clients seek VIP treatment
Chase Travel Entertainment Solutions specializes in high-stakes, customized and discreet travel arrangements for A-list celebrities and entertainment clients, leveraging its scale and focus for growth in the entertainment sector.
Who Gets to Shape Healthcare?
Howie and Harlan discuss how AI is transforming medical research and publishing, the growing role of consumer health platforms and wearables, new advances in stroke treatment, and the debate over rising hospital costs. They also examine the FDA’s approval of flavored vaping products and the nomination of a new surgeon general.
Scientists discover the nutrient that can supercharge cellular energy
Researchers discovered that leucine, a nutrient found in protein-rich foods, can supercharge mitochondria by protecting crucial energy-producing proteins inside cells. The breakthrough uncovers a powerful new link between diet and cellular energy — with possible implications for cancer and metabolic disease treatments.
MIT scientists discover amino acid that helps the gut heal itself
MIT scientists have identified cysteine — an amino acid found in foods like meat, dairy, beans, and nuts — as a potent trigger for intestinal repair. In mice, a cysteine-rich diet activated immune cells that released healing signals, helping stem cells rebuild damaged intestinal tissue after radiation exposure. Researchers say the discovery could eventually lead to new dietary therapies for cancer patients suffering from treatment-related gut damage.
New obesity treatment may help preserve muscle during weight loss
Gwyneth Paltrow and neuroscientist Andrew Huberman explore retatrutide, a new triple-agonist GLP-1 therapy said to reduce side effects and spare muscle.
Nearly 60% of college students with a psychosis diagnosis are not receiving the recommended mental health treatment
Despite a low overall prevalence of psychosis in the United States, affecting three percent of the population, this condition is a serious public health concern because people often delay seeking care ...
Cancer, Blood Research Tops Science Schedule as Spacewalk Preps Continue
The Expedition 74 crew continued exploring ways to advance cancer treatments and prevent excessive bleeding aboard the International Space Station on Wednesday. The orbital residents are also unpacking a U.S. cargo spacecraft while preparing spacesuits for an upcoming spacewalk.
Can we harness quantum effects to create a new kind of healthcare?
Experiments hint that quantum mechanisms are vital to the machinery of life. Now researchers are exploring if these effects help to explain the success of an array of puzzling health treatments
What to know about Ebola and how it spreads, as the outbreak widens
The outbreak has been linked to nearly 600 suspected cases and 139 deaths in the Democratic Republic of Congo. This specific virus has no available vaccines or treatments.
Scientists found a hidden Alzheimer’s trigger and shut it down
A newly identified enzyme called IDOL could become a major new target in the fight against Alzheimer’s disease. Researchers found that removing it from neurons sharply reduced amyloid plaques and improved key brain processes linked to resilience and communication between cells. The discovery may lead to future treatments that go beyond slowing Alzheimer’s — potentially helping protect the brain from further decline.
Meet a Health Hero: Cheryl Colleluori of HEADstrong Foundation
This 2025 finalist carried on her son’s legacy after his death from lymphoma, helping cancer patients find free lodging during treatments.
Scientists Discover a Fat-Burning 'Dial' That Could Help Strengthen Bones
"Opens the door to a new kind of treatment."
Why renaming this common hormonal disorder is a huge deal
You probably know someone who has a condition that, until last week, was known as PCOS, or polycystic ovary syndrome. It affects one in eight reproductive-aged women. But despite it being such a common disorder, patients are often misdiagnosed and have delayed treatment. Now, medical professionals are trying to change that. After 15 years of work, the condition has been renamed to PMOS, or polyendocrine metabolic ovarian syndrome. The new name reflects the real driver of the condition: disruptions in hormones. But how much can changing a name really do? Click here to access resources about PMOS in multiple languages. Interested in more science? Email us your question at shortwave@npr.org.Listen to every episode of Short Wave sponsor-free and support our work at NPR by signing up for Short Wave+ at plus.npr.org/shortwave.
Dartmouth Health study could point way to sustained weight loss for those who stop using GLP-1 drugs
GLP-1 drugs have transformed obesity treatment, but many patients regain weight after stopping the medication. A new study could point the way to a solution.
Scientists found a fat-burning switch that affects bone strength
Scientists have discovered a previously unknown mechanism that helps burn fat and could strengthen bones through new treatments.
Springfield losing its detox beds as Behavioral Health Network moves toward transitional treatment
Springfield's Carlson Recovery Center is ending detox beds with 24/7 medical supervisor due to staffing, shifting to less-intensive residential addiction care.
Bergman: ‘The time is now’ to push for breakthroughs in psychedelic treatments
Rep. Jack Bergman (R-Mich.) said on Tuesday that “the time is now” to push for breakthroughs in psychedelic treatments given President Trump’s recent support for this field of res…
Robin Williams’ son Zak Williams slated to speak at mental health summit in Fort Wayne
The 2014 death of Zak’s father prompted him to explore treatment for his own mental health struggles.
Watch live: Rethinking Psychedelic Treatment for America’s Mental Health Crisis
Psychiatry is at an inflection point — and the stakes are high. Mental illness costs the U.S. economy more than $280 billion annually, drives veteran suicide rates, and places mounting strain on ev…
Barcelona Institute for Global Health: Expanded TB screening does not speed up treatment initiation or improve survival in hospitalised patients with HIV
Adding molecular tests on sputum, urine and stool samples does not appear to outperform the standard WHO-recommended diagnostic approach.
State health officials step in amid ongoing Wintergreen wastewater issues in Nelson County
State health officials have joined the response to ongoing wastewater overflow issues at the Wintergreen Wastewater Treatment Plant in Nelson County.
Hidden GI struggles in children with autism spark $12.9M Duke-UNC Health study
A Raleigh fourth grader is helping researchers highlight a hidden struggle for many children with autism: chronic GI issues. Duke Health and UNC Health are launching a $12.9 million national study aimed at improving treatment options.
Whoa! Netflix is Sending Narnia Heading to Theaters...What This Means for the Future of Film
(Welcome to the “Most Important Story of the Week”, my bi-weekly strategy column analyzing the most important (but often not buzziest) news story of the last two weeks. I’m the Entertainment Strategy Guy, a former streaming executive who now analyzes business strategy in the entertainment industry. Please subscribe.) Here’s a funny thing about the debate over whether streamers should release their movies in theaters first: Both sides think the other side represents the “conventional wisdom”. If you’ve been reading me for any amount of time, or even just scanned my front page, you know I think movies make more money by having a robust theatrical window compared to going straight-to-streaming. I’ve published thousands of words on this topic. And for years, I felt like I was standing up to a wave of opposition. See, while the “put your films in theaters to make money” take was obvious at any point before 2019, post-streaming revolution, most of the trendy thinkers took the opposite point of view. Big names argued that Netflix putting their film straight-to-streaming (“S-to-S” from here on out) actually made more money. Netflix was “disrupting” theaters, just as they disrupted Blockbuster Video, and since innovation is always good, this too was a great idea. This thinking then leaked into the mainstream business outlets like the Wall Street Journal and Bloomberg. I read many articles whose take boiled down to “Netflix makes tons of money from S-to-S releases” and “theaters were in structural decline” anyways. Covid-19 shutting down theaters and the 2023 strikes shutting down film production seemingly justified this point of view, as the box office struggled to return to 2017-2019 heights. Yet I’ve also read folks arguing the opposite point: the conventional wisdom says to put films in theaters! From some writers’ points of view, “everyone” actually agrees/agreed with my “send your films to theaters” take—especially the stodgy traditional studios—and folks still didn’t understand Netflix’s genius. I feel like, for the last two years, many people have argued this point as if it’s conventional wisdom. You know what? I may have been wrong. At this point, the “S-to-S strategy makes money” might be the minority viewpoint. Especially with the news this month that Netflix will put at least one film—Greta Gerwig’s Narnia film The Magician’s Nephew—in theaters in 2027 for a full 49-day run is big news. So that’s the story of the week, but I’ll also explain why they’re making this move now and why Netflix may not completely embrace theaters, along with other topics, like how I don’t buy Disney’s “super app” strategy, the latest good news out of the unions, my take on the latest attacks against free speech, and a whole lot more. Let’s get started. Subscribe Most Important Story of the Week - Netflix Goes to Theaters! Listen, I promise not to victory lap too hard today. As I just wrote, I’ve argued against sending films straight-to-streaming for—checks calendar—eight years now. Since 2018. Yikes. That’s a long time. And for years, others painted my thinking as “conventional” in that I was standing up for the status quo against trendy, cool disruption. And that’s not cool! But math is math, and I never could make the S-to-S numbers work. The only thing that ever enabled that model was Wall Street’s brief exuberance for it. It seems like the heads of Netflix now agree with me. (There were always rumors that former head of film for Netflix Scott Stuber argued internally for theatrical releases as well.) As they announced: “The Magician’s Nephew_—the first film in a Narnia series of films—will open on 12-Feb-2027, with a 49 day theatrical exclusive run.”_ I’m a little surprised at how little coverage this big change actually got. Credit to Bloomberg for leading with it and Matt Belloni’s The Town for highlighting it with the provocatively titled podcast “Hell Hath Frozen Over”. But after that? Instead of getting as much coverage as, say, the FCC’s latest egregious crackdown on free speech, this news story got crickets. But it’s massively more important for the future business of entertainment. So let’s start with the obvious question… Why Put Your Movies in Theaters? So…why should Netflix put (some!) of their movies in theaters? Well, I’ve already written that in a very, very, very long article from 2022: [ ](https://entertainment.substack.com/p/the-data-is-in-theatrical-films-massively) [ The Data Is In: Theatrical Films Massively Outperform Straight-To-Streaming Films ](https://entertainment.substack.com/p/the-data-is-in-theatrical-films-massively) Entertainment Strategy Guy · April 5, 2023 [ Read full story ](https://entertainment.substack.com/p/the-data-is-in-theatrical-films-massively) To summarize, theatrical runs make much more money, especially blockbusters, because they earn more money per viewing,1 and that helps boost home entertainment sales. Theatrical films also perform as well or better than the streaming-only films. Now, partially this is driven by increased marketing for said films, but said marketing ultimately boosts the awareness of the movies and drives improved streaming and library performance as well. Again, I’ve made this case after reviewing the economic models and streaming data for years. Just last week, Emily Horgan also made the case for kids films! Yes, it is probably conventional wisdom, but that’s also because it’s true! I’d also argue we’ve seen a lot of data in the various studios’ behavior. As I’ve noted before, the more a studio needs to make money, the likelier they are to put films in theaters. As such, Disney, Universal, Warner Bros., Paramount and Sony all send their major films to theaters. Even if they once made a big S-to-S push (*cough* Disney *cough*), they’ve since relented and returned to theaters. The tech companies don’t need to make money, per se, so it took them years to embrace theaters. Apple doesn’t need to make money because it doesn’t disclose their (likely) Quibi-sized losses each year. (They fear bad press more than losing money.) Amazon announced two years ago that they planned to make Amazon-MGM Studios/Prime Video profitable on its own, and guess what? Now they’re putting films in theaters. That leaves Netflix. They’re in between the “no need to make money at all” and the “desperately need to make money to offset linear TV declines”, so they had less pressure to put some films in theaters. Plus, for years, they were the sexy disruptor, and Wall Street rewarded them for that. (Honestly, they still do.) Yet, even Netflix likely saw the money they were leaving on the table (I’ve estimated it at an easy billion dollars before) so they changed their course. I heard one pundit argue that, because Netflix already makes so much money, they don’t need to make more money, which sort of goes against everything I’ve ever learned about business and economics. Again, to be super-nuanced, sending “films to theaters” does not mean EVERY film. TV movies have been a thing for decades. Lifetime films, Hallmark holiday films, Disney Channel Original Movies, and so on, don’t need theatrical runs. But films above a certain budget level (say $25 to 50 million) almost certainly need theaters to maximize their revenue. The Scenarios (with a Dose of Skepticism) Now time for some skepticism: it won’t surprise me at all if Netflix re-changes course. Specifically, Netflix announced that their Narnia film will go to theaters. And I’d bet anything we see KPop Demon Hunters 2: The Huntering2 also goes to theaters, cause it’s the surest hit outside of a Disney animated sequel right now. But how much does Netflix truly commit to theaters? They’ve already tried to emphasize that this is a one-off move. I see three broad scenarios:
A hidden barrier to starting a family
Endometriosis is a widespread disease affecting at least one in eight women, often leading to infertility, which can be prevented with earlier diagnosis and treatment.
WHO declares Ebola outbreak in Congo and Uganda a global health emergency
More than 300 suspected cases and 88 deaths have been reported. The outbreak is caused by the rare Bundibugyo virus, which has no approved treatments or vaccines.
WHO Declares Congo-Uganda Ebola Outbreak Global Health Emergency
The World Health Organization declared an Ebola outbreak in Democratic Republic of Congo and Uganda a public health emergency of international concern, warning that a rare virus strain with no approved vaccine or treatment may already be spreading more widely than detected.
Scientists reverse Alzheimer’s in mice with breakthrough nanotechnology
A new nanotechnology treatment reversed Alzheimer’s symptoms in mice by restoring the brain’s natural cleanup system. The specially engineered nanoparticles helped clear toxic amyloid proteins from the brain and repair the blood-brain barrier, which normally protects and regulates the brain’s environment. In one striking experiment, elderly mice treated with the therapy later behaved like healthy younger mice.
Scientists discover why some cancers survive chemotherapy
Scientists have uncovered a surprising new trick used by one of cancer’s most notorious proteins. MYC, already infamous for fueling runaway tumor growth, also appears to help cancer cells survive by repairing their damaged DNA — including damage caused by chemotherapy and radiation. Researchers found that MYC can rush directly to broken DNA and recruit repair machinery, effectively helping tumors recover from treatments meant to destroy them.
Intercept Health Treatment Foster Care hold event to bring awareness to foster care in Roanoke
On Saturday, Intercept Health’s Treatment Foster Care Team came together in Roanoke to raise awareness of the need for more foster parents in the commonwealth - especially for teens.
Scientists reversed memory loss by recharging the brain’s tiny engines
Researchers have shown for the first time that malfunctioning mitochondria — the cell’s energy generators — may directly cause cognitive decline in neurodegenerative diseases. By creating a new tool that temporarily boosts mitochondrial activity in the brain, scientists restored memory performance in mouse models of dementia. The discovery hints that energy failure inside neurons could happen before brain cells die, potentially offering a new target for future Alzheimer’s treatments.
Scientists find hidden brain nutrient deficit that may fuel anxiety
A major analysis of brain scans found that people with anxiety disorders have noticeably lower levels of choline, a nutrient crucial for healthy brain function. The strongest evidence appeared in the prefrontal cortex, the region tied to emotional control and decision-making. Researchers say the discovery is the first clear chemical brain pattern linked to anxiety and could eventually lead to new nutrition-based treatments.
Scientists find hidden brain nutrient deficit that may fuel anxiety
A major analysis of brain scans found that people with anxiety disorders have noticeably lower levels of choline, a nutrient crucial for healthy brain function. The strongest evidence appeared in the prefrontal cortex, the region tied to emotional control and decision-making. Researchers say the discovery is the first clear chemical brain pattern linked to anxiety and could eventually lead to new nutrition-based treatments.
Scientists discover tiny gut particles that may drive aging and chronic disease
A new study suggests microscopic particles from the gut may actively drive inflammation and chronic diseases associated with aging. Remarkably, gut particles from young animals appeared to counter some aging-related damage in older animals, hinting at new possibilities for future treatments.
5 NFL teams didn't get prime-time treatment. The league told the Jets, Raiders, Titans, Dolphins and Cardinals what it thinks of rebuilds
How City of Hope is turning microbiome science into better cancer care
For years, clues pointed to the gut microbiome as a key factor in cancer treatment outcomes. Recent advances in gene sequencing are now clarifying its influence on how patients respond to therapy. At City of Hope, this clarity has catalyzed a more comprehensive model for microbiome science in cancer care. We define the microbiome as […]